Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
CHDN
|
Daniel P Harrington
Director |
BUY
Grant, award, or other acquisition
|
Direct | 174 Added 0.3% |
-
|
Mar 31
2022 |
OC
|
Kelly Schmidt
Vice President and Controller |
SELL
Payment of exercise price or tax liability
|
Direct | 1,308 Reduced 7.2% |
$119,682
$91.5 p/Share
|
Mar 31
2022 |
H
|
Michael A Rocca
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 2,352 Added 9.12% |
-
|
Mar 31
2022 |
HII
|
Philip M. Bilden
Director |
BUY
Grant, award, or other acquisition
|
Direct | 169 Added 4.44% |
$33,705
$199.44 p/Share
|
Mar 31
2022 |
HII
|
Augustus L Collins
Director |
BUY
Grant, award, or other acquisition
|
Indirect | 156 Added 2.69% |
$31,113
$199.44 p/Share
|
Mar 31
2022 |
JLL
|
Hugo Bague
Director |
BUY
Grant, award, or other acquisition
|
Direct | 104 Added 0.54% |
$24,904
$239.46 p/Share
|
Mar 31
2022 |
JLL
|
Samuel A Di Piazza
Director |
BUY
Grant, award, or other acquisition
|
Direct | 104 Added 0.85% |
$24,904
$239.46 p/Share
|
Mar 31
2022 |
JLL
|
Tina L. Ju
Director |
BUY
Grant, award, or other acquisition
|
Direct | 104 Added 13.56% |
$24,904
$239.46 p/Share
|
Mar 31
2022 |
JLL
|
Sheila A Penrose
Director |
BUY
Grant, award, or other acquisition
|
Direct | 104 Added 0.2% |
$24,904
$239.46 p/Share
|
Mar 31
2022 |
JLL
|
Efrain Rivera
Director |
BUY
Grant, award, or other acquisition
|
Direct | 104 Added 10.19% |
$24,904
$239.46 p/Share
|
Mar 31
2022 |
CLVT
|
Andrew Miles Snyder
Director |
BUY
Grant, award, or other acquisition
|
Direct | 633 Added 14.6% |
$10,609
$16.76 p/Share
|
Mar 31
2022 |
CLVT
|
Roxane White
Director |
BUY
Grant, award, or other acquisition
|
Direct | 633 Added 7.55% |
$10,609
$16.76 p/Share
|
Mar 31
2022 |
CLVT
|
Balakrishnan S Iyer
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 77 Reduced 0.49% |
$1,291
$16.76 p/Share
|
Mar 31
2022 |
CLVT
|
Balakrishnan S Iyer
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,566 Added 9.0% |
$26,246
$16.76 p/Share
|
Mar 31
2022 |
CLVT
|
Sheryl G. Von Blucher
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 607 Reduced 0.02% |
$10,173
$16.76 p/Share
|
Mar 31
2022 |
CLVT
|
Sheryl G. Von Blucher
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,566 Added 0.06% |
$26,246
$16.76 p/Share
|
Mar 31
2022 |
CLVT
|
Jane L Okun Bomba
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 88 Reduced 0.13% |
$1,475
$16.76 p/Share
|
Mar 31
2022 |
CLVT
|
Jane L Okun Bomba
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,715 Added 2.4% |
$28,743
$16.76 p/Share
|
Mar 31
2022 |
CLVT
|
Richard Roedel
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 58 Reduced 0.52% |
$972
$16.76 p/Share
|
Mar 31
2022 |
CLVT
|
Richard Roedel
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,267 Added 10.18% |
$21,235
$16.76 p/Share
|
Mar 31
2022 |
MORN
|
Joseph D Mansueto
Executive Chairman |
SELL
Open market or private sale
|
Direct | 3,707 Reduced 0.03% |
$1,035,884
$279.44 p/Share
|
Mar 31
2022 |
ABMD
|
David M Weber
CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct | 7,500 Reduced 6.06% |
$2,550,000
$340.0 p/Share
|
Mar 31
2022 |
ABMD
|
Andrew J Greenfield
VP, CHIEF COMMERCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct | 25 Added 0.06% |
-
|
Mar 31
2022 |
ABMD
|
Michael R Minogue
CHAIRMAN, PRESIDENT, CEO |
BUY
Grant, award, or other acquisition
|
Direct | 43 Added 0.02% |
-
|
Mar 31
2022 |
WTRG
|
David Alan Ciesinski
Director |
BUY
Grant, award, or other acquisition
|
Direct | 532 Added 25.61% |
$27,483
$51.66 p/Share
|
Mar 31
2022 |
WTRG
|
Daniel J Hilferty Iii
Director |
BUY
Grant, award, or other acquisition
|
Direct | 532 Added 2.28% |
$27,483
$51.66 p/Share
|
Mar 31
2022 |
WTRG
|
Francis Osarume Idehen
Director |
BUY
Grant, award, or other acquisition
|
Direct | 532 Added 7.53% |
$27,483
$51.66 p/Share
|
Mar 31
2022 |
WTRG
|
Christopher C Womack
Director |
BUY
Grant, award, or other acquisition
|
Direct | 532 Added 7.53% |
$27,483
$51.66 p/Share
|
Mar 31
2022 |
WTRG
|
Elizabeth B Amato
Director |
BUY
Grant, award, or other acquisition
|
Direct | 532 Added 6.04% |
$27,483
$51.66 p/Share
|
Mar 31
2022 |
WTRG
|
Ellen T Ruff
Director |
BUY
Grant, award, or other acquisition
|
Direct | 532 Added 1.53% |
$27,483
$51.66 p/Share
|
Mar 31
2022 |
WTRG
|
Lee C Stewart
Director |
BUY
Grant, award, or other acquisition
|
Direct | 532 Added 2.83% |
$27,483
$51.66 p/Share
|
Mar 31
2022 |
TAP
|
Nessa O'Sullivan |
BUY
Grant, award, or other acquisition
|
Direct | 469 Added 4.23% |
-
|
Mar 31
2022 |
TAP
|
Louis Vachon |
BUY
Grant, award, or other acquisition
|
Direct | 539 Added 1.58% |
-
|
Mar 31
2022 |
TAP
|
Roger G. Eaton |
BUY
Grant, award, or other acquisition
|
Direct | 563 Added 1.37% |
-
|
Mar 31
2022 |
TAP
|
Douglas D. Tough |
BUY
Grant, award, or other acquisition
|
Direct | 235 Added 0.83% |
-
|
Mar 31
2022 |
TAP
|
Charles M Herington |
BUY
Grant, award, or other acquisition
|
Direct | 235 Added 0.51% |
-
|
Mar 31
2022 |
BAH
|
Judith Dotson
Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct | 936 Reduced 1.81% |
$82,218
$87.84 p/Share
|
Mar 31
2022 |
BAH
|
Susan L Penfield
EVP & Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,702 Reduced 17.01% |
$149,504
$87.84 p/Share
|
Mar 31
2022 |
BAH
|
Scott M Murphy
VP, PAO & Controller |
SELL
Payment of exercise price or tax liability
|
Direct | 32 Reduced 1.18% |
$2,811
$87.84 p/Share
|
Mar 31
2022 |
BAH
|
Horacio Rozanski
President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 9,649 Reduced 1.69% |
$847,568
$87.84 p/Share
|
Mar 31
2022 |
BAH
|
Elizabeth M Thompson
EVP & Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 901 Reduced 2.94% |
$79,144
$87.84 p/Share
|
Mar 31
2022 |
BAH
|
Kristine Anderson
EVP & Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,584 Reduced 6.7% |
$139,139
$87.84 p/Share
|
Mar 31
2022 |
BAH
|
Karen M Dahut
Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct | 3,580 Reduced 2.26% |
$314,467
$87.84 p/Share
|
Mar 31
2022 |
BAH
|
Lloyd Howell Jr
EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 2,618 Reduced 1.6% |
$229,965
$87.84 p/Share
|
Mar 31
2022 |
BAH
|
Nancy Laben
EVP & Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,903 Reduced 17.2% |
$167,160
$87.84 p/Share
|
Mar 31
2022 |
BG
|
Christos Dimopoulos
Co-President, Agribusiness |
SELL
Payment of exercise price or tax liability
|
Direct | 172 Reduced 0.31% |
$18,978
$110.34 p/Share
|
Mar 31
2022 |
ELS
|
Roger Maynard |
SELL
Sale (or disposition) back to the issuer
|
Direct | 11,881 Reduced 4.41% |
-
|
Mar 31
2022 |
HWM
|
John C Plant
Executive Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 215,227 Reduced 40.65% |
$7,735,258
$35.94 p/Share
|
Mar 31
2022 |
HWM
|
John C Plant
Executive Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 495,000 Added 48.32% |
-
|
Mar 31
2022 |
ZI
|
Henry Schuck
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 20,380 Reduced 0.13% |
$1,223,208
$60.02 p/Share
|
Mar 31
2022 |